← Back to Cancer Screening

Foundation Medicine

Cancer patients seeking targeted therapy options

Variable
FDA approved (CDx)
Detects: 324 genes
Sample: Tumor tissue
Results: 14-21 days

Test Performance

Sensitivity

N/A

Specificity

N/A

Detection Method

Genomic profiling

Turnaround

14-21 days

Key Features

324-gene genomic panel • 324 genes • FDA-approved companion diagnostic • Treatment matching

Who It's For

Important Notes

Not for screening - analyzes existing tumors. Industry standard for tumor genomic profiling (324 genes).

Learn more about Foundation Medicine

Discuss with your physician before ordering.

Visit Foundation MedicineCompare All